Viking Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing novel therapies for metabolic and endocrine disorders. Here's what investors should know.
Overview: Top US crypto influencers in 2025 guide innovation, education, and market trends, shaping the future of digital ...
Stocktwits on MSN
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction
The company now expects an investment commitment from Factor, in addition to existing cash, to support its planned operations ...
Analyst John Colantuoni upgraded shares of DoorDash to Buy from Hold and raised his price target on the stock to $260 from ...
The chancellor has asked the Competition and Markets Authority (CMA) to look into the high costs of dental treatment amid ...
24/7 Wall St. on MSN
IREN Regains Momentum. Here’s Why You Should Buy Now
The AI infrastructure sector is going through a rough patch, with shares of high-flyers like CoreWeave (NASDAQ:CRWV), Nebius Group (NASDAQ:NBIS) and other “neocloud” providers tumbling amid valuation ...
Blue Owl Offered a Way Out to Private Credit Investors. Why It’s a Tough Sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback